Skip to content

About our Medical Products Technologies

At Ingenew Pharma, we are leveraging our fundamental understanding of immunology and inflammatory process to advance therapeutic solutions initially in the field of oncology, neurology, dermatology and urology. We remain opportunistic with regards to therapeutic fields whenever our core competencies can contribute to address unmet medical needs, our initiative for COVID-19 being one example.

Products

Indications

Discovery

Pre-clinical

Clinical

Market

HesperCo™

COVID-19

ING-012

Eczema

ING-035

Actinic Keratosis

ING-12

Neuro-cognitive

ING-260

Basal Cell Carcinoma

ING-251

Squamous Cell Carcinoma

ING-242

Interstitial cystitis

ING-332

Glioblastoma

ING-224

Melanoma

Products

HesperCo™

Indications

COVID-19

Discovery

Pre-Clinical

Clinical

Market

Products

Melanoma

Indications

Eczema

Discovery

Pre-Clinical

Clinical

Market

Products

ING-035

Indications

Actinic Keratosis

Discovery

Pre-Clinical

Clinical

Market

Products

ING-12

Indications

Neuro-cognitive

Discovery

Pre-Clinical

Clinical

Market

Products

ING-260

Indications

Basal Cell Carcinoma

Discovery

Pre-Clinical

Clinical

Market

Products

ING-251

Indications

Squamous Cell Carcinoma

Discovery

Pre-Clinical

Clinical

Market

Products

ING-242

Indications

Interstitial cystitis

Discovery

Pre-Clinical

Clinical

Market

Products

ING-332

Indications

Glioblastoma

Discovery

Pre-Clinical

Clinical

Market

Products

ING-224

Indications

Melanoma

Discovery

Pre-Clinical

Clinical

Market